馬偕醫學大學機構典藏(MacKay Medical University Institutional Repository):Item 987654321/2791
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 1657/1756
造访人次 : 3729214      在线人数 : 188
RC Version 5.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 进阶搜寻

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://140.112.115.32:8080/ir/handle/987654321/2791

题名: Artesunate as a glycoprotein VI antagonist for preventing platelet activation and thrombus formation
作者: Wan-Jung Lu;Chung-Hsin Tsai;Ray-Jade Chen;Li-Ting Huang;Ting-Yu Chen;Lih-Chyang Chen;Hsueh-Hsiao Wang;Hsien-Yu Peng;Yu-Yo Sun;Kuan-Hung Lin
贡献者: 視光學系
关键词: Artesunate;GPVI;Platelet activation;Thrombus formation;Cardiovascular diseases
日期: 2022-09-01
上传时间: 2025-08-11 14:43:55 (UTC+8)
摘要: Platelets play a crucial role on hemostasis and are also involved in cardiovascular diseases, such as heart attack and stroke. Artesunate has been reported to possess multiple biological activities, including antitumor and anti-inflammatory activities. However, its effect on platelet activation remains unclear. Thus, we explored the detailed mechanisms underlying its antiplatelet effect. For the in vitro study, the data indicated that artesunate inhibited platelet aggregation induced by collagen, but not thrombin or U46619, indicating that artesunate may selectively inhibit collagen-mediated platelet activation Artesunate also blocked glycoprotein VI (GPVI) downstream signaling, including Syk, PLCγ2, PKC, Akt, and MAPKs. Moreover, artesunate could compete with collagen for binding to collagen receptor and bind to human recombinant GPVI with a high affinity (KD = 44 nM), indicating that it may directly interfere with GPVI. Artesunate also reduced collagen-induced granule release, calcium mobilization, and GPIIbIIIa activation. For the in vivo study, artesunate markedly prevented pulmonary thrombosis and delayed platelet thrombus formation in mesenteric veins and arteries but had minimal effects on hemostasis. In conclusion, we for the first time demonstrated that artesunate acts as a GPVI antagonist and effectively prevents platelet activation and thrombus formation with minimal risk of bleeding, highlighting its therapeutic potential in cardiovascular diseases.
關聯: Biomedicine & Pharmacotherapy, 153, 113531. https://doi.org/10.1016/j.biopha.2022.113531
显示于类别:[視光學系] 期刊論文

文件中的档案:

档案 大小格式浏览次数
index.html0KbHTML1检视/开启


在MMUIR中所有的数据项都受到原著作权保护.

 


DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈